The temporal evaluation of RAS and BRAF mutation by liquid biopsy at progression after bevacizumab combinations in patients with metastatic colorectal cancer (mCRC).

Irem Bilgetekin; Mehmet Dogan; Cengiz Karacin; Fatma Bugdayci Basal; Ece Esin; Gokhan Ucar; Ozlem Aydin Isak; Goksen Inanc Imamoglu; Gul Sema Yildiran Keskin; Ismail Erturk; Burak Yasin Aktas; Naziyet Kose Baytemur; Kubra Aydin; Selcuk Cemil Ozturk; Bulent Aksel; Nuri Karadurmus; Olcay Kandemir; Berna Oksuzoglu; Umut Demirci

doi:10.1200/JCO.2021.39.15_suppl.e15587

The temporal evaluation of RAS and BRAF mutation by liquid biopsy at progression after bevacizumab combinations in patients with metastatic colorectal cancer (mCRC).

Irem Bilgetekin
, Mehmet Dogan
, Cengiz Karacin
, Fatma Bugdayci Basal
, Ece Esin
, Gokhan Ucar
, Ozlem Aydin Isak
, Goksen Inanc Imamoglu
, Gul Sema Yildiran Keskin
, Ismail Erturk
, Burak Yasin Aktas
, Naziyet Kose Baytemur
, Kubra Aydin
, Selcuk Cemil Ozturk
, Bulent Aksel
, Nuri Karadurmus
, Olcay Kandemir
, Berna Oksuzoglu
, Umut Demirci

Division of Internal Medicine (Medicine)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	39
Issue number	15
DOIs	https://doi.org/10.1200/JCO.2021.39.15_suppl.e15587
Publication status	Published - 20 May 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1200/JCO.2021.39.15_suppl.e15587

Cite this

Bilgetekin, I., Dogan, M., Karacin, C., Basal, F. B., Esin, E., Ucar, G., Isak, O. A., Imamoglu, G. I., Keskin, G. S. Y., Erturk, I., Aktas, B. Y., Baytemur, N. K., Aydin, K., Ozturk, S. C., Aksel, B., Karadurmus, N., Kandemir, O., Oksuzoglu, B., & Demirci, U. (2021). The temporal evaluation of RAS and BRAF mutation by liquid biopsy at progression after bevacizumab combinations in patients with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology, 39(15). https://doi.org/10.1200/JCO.2021.39.15_suppl.e15587

@article{c964e06fa9af4379b267ffc238eef970,

title = "The temporal evaluation of RAS and BRAF mutation by liquid biopsy at progression after bevacizumab combinations in patients with metastatic colorectal cancer (mCRC).",

author = "Irem Bilgetekin and Mehmet Dogan and Cengiz Karacin and Basal, \{Fatma Bugdayci\} and Ece Esin and Gokhan Ucar and Isak, \{Ozlem Aydin\} and Imamoglu, \{Goksen Inanc\} and Keskin, \{Gul Sema Yildiran\} and Ismail Erturk and Aktas, \{Burak Yasin\} and Baytemur, \{Naziyet Kose\} and Kubra Aydin and Ozturk, \{Selcuk Cemil\} and Bulent Aksel and Nuri Karadurmus and Olcay Kandemir and Berna Oksuzoglu and Umut Demirci",

year = "2021",

month = may,

day = "20",

doi = "10.1200/JCO.2021.39.15\_suppl.e15587",

language = "English",

volume = "39",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "15",

}

Bilgetekin, I, Dogan, M, Karacin, C, Basal, FB, Esin, E, Ucar, G, Isak, OA, Imamoglu, GI, Keskin, GSY, Erturk, I, Aktas, BY, Baytemur, NK, Aydin, K, Ozturk, SC, Aksel, B, Karadurmus, N, Kandemir, O, Oksuzoglu, B & Demirci, U 2021, 'The temporal evaluation of RAS and BRAF mutation by liquid biopsy at progression after bevacizumab combinations in patients with metastatic colorectal cancer (mCRC).', Journal of Clinical Oncology, vol. 39, no. 15. https://doi.org/10.1200/JCO.2021.39.15_suppl.e15587

TY - JOUR

T1 - The temporal evaluation of RAS and BRAF mutation by liquid biopsy at progression after bevacizumab combinations in patients with metastatic colorectal cancer (mCRC).

AU - Bilgetekin, Irem

AU - Dogan, Mehmet

AU - Karacin, Cengiz

AU - Basal, Fatma Bugdayci

AU - Esin, Ece

AU - Ucar, Gokhan

AU - Isak, Ozlem Aydin

AU - Imamoglu, Goksen Inanc

AU - Keskin, Gul Sema Yildiran

AU - Erturk, Ismail

AU - Aktas, Burak Yasin

AU - Baytemur, Naziyet Kose

AU - Aydin, Kubra

AU - Ozturk, Selcuk Cemil

AU - Aksel, Bulent

AU - Karadurmus, Nuri

AU - Kandemir, Olcay

AU - Oksuzoglu, Berna

AU - Demirci, Umut

PY - 2021/5/20

Y1 - 2021/5/20

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000708120301251&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1200/JCO.2021.39.15_suppl.e15587

DO - 10.1200/JCO.2021.39.15_suppl.e15587

M3 - Meeting Abstract

SN - 0732-183X

VL - 39

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -

The temporal evaluation of RAS and BRAF mutation by liquid biopsy at progression after bevacizumab combinations in patients with metastatic colorectal cancer (mCRC).

UN SDGs

Access to Document

Other files and links

Cite this